litlas
ログインアカウント作成

Jack A. Schalken

1985–2024 年に発表

131
論文数
21,431
被引用数
87
h 指数
129
i10 指数

被引用数

Jack A. Schalken の年別被引用数1985 年: 被引用 1 件1986 年: 被引用 5 件1987 年: 被引用 7 件1988 年: 被引用 14 件1989 年: 被引用 11 件1990 年: 被引用 25 件1991 年: 被引用 38 件1992 年: 被引用 38 件1993 年: 被引用 79 件1994 年: 被引用 75 件1995 年: 被引用 61 件1996 年: 被引用 73 件1997 年: 被引用 93 件1998 年: 被引用 82 件1999 年: 被引用 90 件2000 年: 被引用 129 件2001 年: 被引用 147 件2002 年: 被引用 109 件2003 年: 被引用 128 件2004 年: 被引用 125 件2005 年: 被引用 124 件2006 年: 被引用 115 件2007 年: 被引用 137 件2008 年: 被引用 170 件2009 年: 被引用 174 件2010 年: 被引用 203 件2011 年: 被引用 177 件2012 年: 被引用 198 件2013 年: 被引用 224 件2014 年: 被引用 206 件2015 年: 被引用 175 件2016 年: 被引用 205 件2017 年: 被引用 181 件2018 年: 被引用 122 件2019 年: 被引用 481 件2020 年: 被引用 479 件2021 年: 被引用 494 件2022 年: 被引用 333 件2023 年: 被引用 249 件2024 年: 被引用 356 件2025 年: 被引用 175 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,023 件、この内訳の 25.6%中国: 引用元論文 717 件、この内訳の 9.1%イギリス: 引用元論文 501 件、この内訳の 6.3%ドイツ: 引用元論文 424 件、この内訳の 5.3%オランダ: 引用元論文 393 件、この内訳の 5%カナダ: 引用元論文 339 件、この内訳の 4.3%イタリア: 引用元論文 335 件、この内訳の 4.2%フランス: 引用元論文 269 件、この内訳の 3.4%日本: 引用元論文 240 件、この内訳の 3%スペイン: 引用元論文 205 件、この内訳の 2.6%オーストラリア: 引用元論文 195 件、この内訳の 2.5%ベルギー: 引用元論文 161 件、この内訳の 2%
0%25.6%その他 26.7%

機関

分野

  • Medicine52.9%
  • Biochemistry, Genetics and Molecular Biology40.6%
  • Immunology and Microbiology1.3%
  • Engineering1.2%
  • Neuroscience0.9%
  • Chemistry0.8%
  • その他2.3%

トピック

  • Prostate Cancer Treatment and Research10.3%
  • Prostate Cancer Diagnosis and Treatment6.4%
  • Cancer-related molecular mechanisms research3.9%
  • Wnt/β-catenin signaling in development and cancer2.8%
  • Cancer Cells and Metastasis2.6%
  • RNA modifications and cancer2.3%
  • その他71.7%

共著者

全論文

検索で開く
  1. Detection and localization of early- and late-stage cancers using platelet RNA

    著者: Sjors G. J. G. In ‘t Veld, Mohammad Arkani, Edward P. Post, Mafalda Antunes‐Ferreira, Silvia D’Ambrosi, Daan C.L. Vessies, Lisa Vermunt, Adrienne Vancura, Mirte Muller, Anna-Larissa N. Niemeijer, Jihane Tannous, Laura L. Meijer, Tessa Y. S. Le Large, Giulia Mantini, Niels E. Wondergem, Kimberley M. Heinhuis, Sandra van Wilpe, J. Smits, Esther E.E. Drees, Eva Roos, Cyra E Leurs, Lee-Ann Tjon Kon Fat, Ewoud J. van der Lelij, Govert Dwarshuis, Maarten J. Kamphuis, Lisanne E. Visser, Romée Harting, Annemijn Gregory, Markus Schweiger, Laurine E. Wedekind, Jip Ramaker, Kenn Zwaan, Heleen Verschueren, Idris Bahce, Adrianus J. de Langen, Egbert F. Smit, Michel M. van den Heuvel, Koen J. Hartemink, Marijke J. E. Kuijpers, Mirjam G.A. oude Egbrink, Arjan W. Griffioen, Rafael Rossel, T. Jeroen N. Hiltermann, Elizabeth Lee-Lewandrowski, Kent Lewandrowski, Philip C. De Witt Hamer, Mathilde C.M. Kouwenhoven, Jaap C. Reijneveld, William P. J. Leenders, Ann Hoeben, Irma M. Verdonck‐de Leeuw, C. René Leemans, Robert J. Baatenburg de Jong, Chris H.J. Terhaard, Robert P. Takes, Johannes A. Langendijk, Saskia C.A. de Jager, Adriaan O. Kraaijeveld, Gerard Pasterkamp, Minke Smits, Jack A. Schalken, Sylwia Łapińska‐Szumczyk, Anna Łojkowska, Anna J. Żaczek, Henk M. Lokhorst, Niels W.C.J. van de Donk, Inger S. Nijhof, Henk‐Jan Prins, Josée M. Zijlstra, Sander Idema, Johannes C. Baayen, Charlotte E. Teunissen, Joep Killestein, Marc G. Besselink, Lindsay Brammen, Thomas Bachleitner‐Hofmann, Farrah J. Mateen, John Th. M. Plukker, Michal Heger, Quirijn de Mast, Ton Lisman, D. Michiel Pegtel, Harm Jan Bogaard, Jacek Jassem, Anna Supernat, Niven Mehra, Winald R. Gerritsen, Cor D. de Kroon, Christianne Lok, Jurgen M.J. Piek, Neeltje Steeghs, Winan J. van Houdt, Ruud H. Brakenhoff, Gabe S. Sonke, Henk M.W. Verheul, Elisa Giovannetti, Geert Kazemier, Siamack Sabrkhany, Ed Schuuring, Erik A. Sistermans ほか 16 名 - Cancer Cell 2022 被引用: 126

  2. Prevention and early detection of prostate cancer

    著者: Jack Cuzick, Mangesh A. Thorat, Gerald L. Andriole, Otis W. Brawley, Powel H. Brown, Zoran Čulig, Rosalind A. Eeles, Leslie G. Ford, Freddie C. Hamdy, Lars Holmberg, Dragan Ilić, Timothy J. Key, Carlo La Vecchia, Hans Lilja, Michael Marberger, Frank L. Meyskens, Lori M. Minasian, Chris Parker, Howard L. Parnes, Sven Perner, Harry G. Rittenhouse, Jack A. Schalken, Hans Peter Schmid, Bernd J. Schmitz‐Dräger, Fritz H. Schröder, Arnulf Stenzl, Bertrand Tombal, Timothy J Wilt, Alicja Wolk - The Lancet Oncology 2014 被引用: 492

  3. Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

    著者: Sofie H. Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, Edmond M. Kwan, Sarah W.S. Ng, Matti Annala, Gráinne Donnellan, Cameron Herberts, Guillemette E. Benoist, Paul Hamberg, Diederik M. Somford, Inge M. van Oort, Jack A. Schalken, Niven Mehra, Nielka P. van Erp, Alexander W. Wyatt - Clinical Cancer Research 2023 被引用: 56

  4. Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men

    著者: Rianne J. Hendriks, Marloes M. G. van der Leest, Bas Israël, Gerjon Hannink, Anglita Yantisetiasti, Erik B. Cornel, Christina A. Hulsbergen‐van de Kaa, O.S. Klaver, J.P. Michiel Sedelaar, Wim Van Criekinge, Hans de Jong, Peter F.A. Mulders, E. David Crawford, Jeroen Veltman, Jack A. Schalken, Jelle O. Barentsz, Inge M. van Oort - Prostate Cancer and Prostatic Diseases 2021 被引用: 82

  5. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score

    著者: Leander Van Neste, Rianne J. Hendriks, Siebren Dijkstra, Geert Trooskens, Erik B. Cornel, Sander A. Jannink, Hans de Jong, Daphne Hessels, Frank Smit, Willem J. G. Melchers, G.H.J.M. Leyten, Theo M. de Reijke, H. Vergunst, Paul J.M. Kil, Ben C. Knipscheer, Christina A. Hulsbergen‐van de Kaa, Peter F.A. Mulders, Inge M. van Oort, Wim Van Criekinge, Jack A. Schalken - European Urology 2016 被引用: 374

  6. PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer

    著者: John Dulos, Gregory J. Carven, Susan J. van Boxtel, Sabine Evers, Lilian J. A. Driessen-Engels, Willemijn Hobo, Monika Górecka, Anton F. J. de Haan, Peter F.A. Mulders, Cornelis J. A. Punt, Joannes F.M. Jacobs, Jack A. Schalken, Egbert Oosterwijk, Hans van Eenennaam, A. Boots - Journal of Immunotherapy 2012 被引用: 318

  7. Liquid biopsy in bladder cancer: State of the art and future perspectives

    著者: Felice Crocetto, Biagio Barone, Matteo Ferro, Gian Maria Busetto, Evelina La Civita, Carlo Buonerba, Giuseppe Di Lorenzo, Daniela Terracciano, Jack A. Schalken - Critical Reviews in Oncology/Hematology 2022 被引用: 91

  8. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

    著者: Marion J.G. Bussemakers, Adrie van Bokhoven, Gerald W. Verhaegh, Frank Smit, Herbert F.M. Karthaus, Jack A. Schalken, F.M.J. Debruyne, Ning Ru, William B. Isaacs - 1999 被引用: 1,062

  9. Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation

    著者: Ying Zhang, Chunling Tang, Paul N. Span, Alan E. Rowan, Tilly Aalders, Jack A. Schalken, Gosse J. Adema, Paul H. J. Kouwer, Mirjam M. Zegers, Marleen Ansems - Advanced Science 2020 被引用: 66

  10. DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

    著者: Daphne Hessels, Jacqueline M. T. Klein Gunnewiek, Inge M. van Oort, Herbert F.M. Karthaus, Geert J.L. van Leenders, Bianca van Balken, Lambertus A. Kiemeney, J. Alfred Witjes, Jack A. Schalken - European Urology 2003 被引用: 702

  11. Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis

    著者: Milena Matuszczak, Jack A. Schalken, Maciej Salagierski - Cancers 2021 被引用: 70

  12. Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer

    著者: Jack A. Schalken, John M. Fitzpatrick - British Journal of Urology 2015 被引用: 144

  13. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions

    著者: Rianne J. Hendriks, Inge M. van Oort, Jack A. Schalken - Prostate Cancer and Prostatic Diseases 2016 被引用: 136

  14. Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer

    著者: G.H.J.M. Leyten, Daphne Hessels, Sander A. Jannink, Frank Smit, Hans de Jong, Erik B. Cornel, Theo M. de Reijke, H. Vergunst, Paul J.M. Kil, Ben C. Knipscheer, Inge M. van Oort, Peter F.A. Mulders, Christina A. Hulsbergen‐van de Kaa, Jack A. Schalken - European Urology 2012 被引用: 358

  15. 68Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study

    著者: Wim van Boxtel, Susanne Lütje, Ilse C.H. van Engen-van Grunsven, Gerald W. Verhaegh, Jack A. Schalken, Marianne A. Jonker, James Nagarajah, Martin Gotthardt, Carla M.L. van Herpen - Theranostics 2020 被引用: 71

  16. Genomic Markers in Prostate Cancer Decision Making

    著者: Vito Cucchiara, Matthew R. Cooperberg, Marc Dall’Era, Daniel W. Lin, Francesco Montorsi, Jack A. Schalken, Christopher P. Evans - European Urology 2017 被引用: 281

  17. The use of PCA3 in the diagnosis of prostate cancer

    著者: Daphne Hessels, Jack A. Schalken - Nature Reviews Urology 2009 被引用: 237

  18. Consensus on molecular imaging and theranostics in prostate cancer

    著者: Stefano Fanti, Silvia Minozzi, Gerald Antoch, Ian Banks, Alberto Briganti, Ignasi Carrió, Arturo Chiti, Noel W. Clarke, Matthias Eiber, Johann S. de Bono, Karim Fizazi, Silke Gillessen, Sam Gledhill, Uwe Haberkorn, Ken Herrmann, Rodney J. Hicks, Frédéric Lecouvet, Rodolfo Montironi, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Jack A. Schalken, Howard I. Scher, Bertrand Tombal, R. Jeroen A. van Moorselaar, Heindrik Van Poppel, Hebert Alberto Vargas, Jochen Walz, Wolfgang Weber, Hans‐Jürgen Wester, Wim J.G. Oyen - The Lancet Oncology 2018 被引用: 118

  19. Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy

    著者: Alexander Haese, Geert Trooskens, Sandra Steyaert, Daphne Hessels, Michael K. Brawer, Virginie Vlaeminck‐Guillem, A. Ruffion, Derya Tilki, Jack A. Schalken, Jack Groskopf, Wim Van Criekinge - The Journal of Urology 2019 被引用: 100

  20. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies

    著者: Emmy Boerrigter, Levi Groen, Nielka P. van Erp, Gerald W. Verhaegh, Jack A. Schalken - Expert Review of Molecular Diagnostics 2019 被引用: 50

  21. Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide

    著者: Guillemette E. Benoist, Rianne J. Hendriks, Peter F.A. Mulders, Winald R. Gerritsen, Diederik M. Somford, Jack A. Schalken, Inge M. van Oort, David M. Burger, Nielka P. van Erp - Clinical Pharmacokinetics 2016 被引用: 104

  22. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1

    著者: Ira Kogan-Sakin, Merav Cohen, Nicole Paland, Shalom Madar, Hilla Solomon, Alina Molchadsky, Ran Brosh, Yosef Buganim, Naomi Goldfinger, Helmut Klocker, Jack A. Schalken, Varda Rotter - Carcinogenesis 2009 被引用: 87

  23. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review

    著者: Maike J.M. Uijen, Gerben Lassche, Adriana C. H. van Engen–van Grunsven, Yuichiro Tada, Gerald W. Verhaegh, Jack A. Schalken, C.M.L. Driessen, Carla M.L. van Herpen - Cancer Treatment Reviews 2020 被引用: 56

  24. Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer

    著者: Sofie H. Tolmeijer, Sandra van Wilpe, Maartje J. Geerlings, Daniel von Rhein, Tineke J. Smilde, Iris S. H. Kloots, Harm Westdorp, M. Coskuntürk, Irma M. Oving, Jolique A. van Ipenburg, Antoine G. van der Heijden, Tom Hofste, Marjan M. Weiss, Jack A. Schalken, Winald R. Gerritsen, Marjolijn J. L. Ligtenberg, Niven Mehra - European Urology Oncology 2023 被引用: 20